Literature DB >> 8387561

Outbreak of Japanese encephalitis on the island of Saipan, 1990.

W S Paul1, P S Moore, N Karabatsos, S P Flood, S Yamada, T Jackson, T F Tsai.   

Abstract

During October 1990, an outbreak of encephalitis occurred on Saipan. Although no virus was isolated, patients seroconverted to Japanese encephalitis (JE) virus, indicating the first known occurrence of JE on US territory since 1947. Ten cases occurred among a population of 40,000. The prevalence of antibody to JE virus among 234 lifelong Saipan residents surveyed after the outbreak was 4.2%. Age, household crowding, and lack of air conditioning were risk factors for infection. The seroprevalence in pigs, which are important amplifying hosts of JE virus, was 96% (n = 52). None of 288 stored serum specimens from lifelong Saipan residents sampled in 1984 were seropositive. These data suggest that JE virus was recently introduced onto Saipan and that peridomestic factors affected the risk of human infection. Transmission of JE virus probably ended with exhaustion of the supply of susceptible amplifying hosts. Surveillance for human cases and seroconversions in pigs during 1991 revealed no evidence of ongoing JE virus transmission.

Entities:  

Mesh:

Year:  1993        PMID: 8387561     DOI: 10.1093/infdis/167.5.1053

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Japanese encephalitis.

Authors:  T Solomon; N M Dung; R Kneen; M Gainsborough; D W Vaughn; V T Khanh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

2.  Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics.

Authors:  N B S Sarkari; A K Thacker; S P Barthwal; V K Mishra; Shiv Prapann; Deepak Srivastava; M Sarkari
Journal:  J Neurol       Date:  2011-06-17       Impact factor: 4.849

3.  Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia.

Authors:  Amy J Schuh; Melissa J Ward; Andrew J Leigh Brown; Alan D T Barrett
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

4.  Monoclonal antibodies against NS3 and NS5 proteins of Japanese encephalitis virus.

Authors:  Zheng Chen; Lin Shao; Jing Ye; Yongmao Li; Shaomei Huang; Huanchun Chen; Shengbo Cao
Journal:  Hybridoma (Larchmt)       Date:  2012-04

5.  Japanese encephalitis (JE) part II: 14 years' follow-up of survivors.

Authors:  N B S Sarkari; A K Thacker; S P Barthwal; V K Mishra; Shiv Prapann; Deepak Srivastava; M Sarkari
Journal:  J Neurol       Date:  2011-06-18       Impact factor: 4.849

Review 6.  Estimated global incidence of Japanese encephalitis: a systematic review.

Authors:  Grant L Campbell; Susan L Hills; Marc Fischer; Julie A Jacobson; Charles H Hoke; Joachim M Hombach; Anthony A Marfin; Tom Solomon; Theodore F Tsai; Vivien D Tsu; Amy S Ginsburg
Journal:  Bull World Health Organ       Date:  2011-08-03       Impact factor: 9.408

7.  Identification of a mutated BHK-21 cell line that became less susceptible to Japanese encephalitis virus infection.

Authors:  Tianbing Ding; Wei Zhang; Wenyu Ma; Junping Ren
Journal:  Virol J       Date:  2011-03-14       Impact factor: 4.099

8.  Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.

Authors:  Keivan Zandi; Leda Bassit; Franck Amblard; Bryan D Cox; Pouya Hassandarvish; Ehsan Moghaddam; Andrew Yueh; Gisele Olinto Libanio Rodrigues; Ingredy Passos; Vivian V Costa; Sazaly AbuBakar; Longhu Zhou; James Kohler; Mauro M Teixeira; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

9.  Comparison of genotypes I and III in Japanese encephalitis virus reveals distinct differences in their genetic and host diversity.

Authors:  Na Han; James Adams; Ping Chen; Zhen-yang Guo; Xiang-fu Zhong; Wei Fang; Na Li; Lei Wen; Xiao-yan Tao; Zhi-ming Yuan; Simon Rayner
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

10.  Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans.

Authors:  Byung-Hak Song; Gil-Nam Yun; Jin-Kyoung Kim; Sang-Im Yun; Young-Min Lee
Journal:  J Microbiol       Date:  2012-08-25       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.